drugset / Trial / NCT00121095
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety, tolerability and anti-tumor effects of treatment with samarium Sm-153 lexidronam in combination with docetaxel in patients with castrate metastatic prostate cancer.
Timeline
- Start
- 2005-07
- Primary completion
- —
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 153 Sm-EDTMP | Unknown | 1 unknown | — |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |